Overall rank by patents
#26,581
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).
The verdict
Ineos holds 10 US patents across 5 technology areas, rank #26,581 of 50,000 tracked assignees.
Ineos US Chemicals Company has been granted 10 US utility patents between 2021 and 2024, placing Ineos US Chemicals Company at rank #26,581 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.2 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a US Corporation, Ineos US Chemicals Company is one of the more focused assignees in the PatentsView dataset. By volume, Ineos sits between Incoe Corporation (10 patents, rank #26,577) and Innerplant, Inc. (10 patents, rank #26,585) - the closest US assignees by grant volume. The composite Innovation Score of 27.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ineos US Chemicals Company's 11.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ineos US Chemicals Company against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Incoe Corporation
10 patents
Indesit Company S.p.A.
10 patents
Industry-Academic Cooperation Group of Kyung Hee Universtiy and
10 patents
Industry-University Cooperation Foundation Sunmoon University
10 patents
Infinityurns, LLC
10 patents
Infosum Limited
10 patents
Infrastructure Renewal Institute of Southern China
10 patents
InnerPlant, Inc.
10 patents
Ineos US Chemicals Company
10 patents
What this shows Ineos holds 10 patents at rank #26,581, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Ineos's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 77% higher than 23% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 6 | 60.0% |
| 2022 | 3 | 30.0% |
| 2024 | 1 | 10.0% |
Top 5 of 5 technology areas
Overall rank by patents
#26,581
Across all tracked assignees
27.4 out of 100
How to use this portfolio
Ineos's 10 grants land it in the top 77% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.